Αποτελέσματα Αναζήτησης
Cost: ~ $530 per cycle "How this cost is calculated" The cost displayed on the protocol is intended as rudimentary guide only for the Australian context. The cost includes anti-cancer drugs only (not antiemetics, supportive medications or consumables), unless otherwise indicated.
23 Φεβ 2021 · The aim of this paper was to evaluate the cost effectiveness of adjuvant AC-TH compared with TCH in the hospital setting for women with early (regional) breast cancer to help guide funding decisions for incurring breast cancer.
1 Μαΐ 2018 · Dose-Dense AC (DD-AC, Doxorubicin + Cyclophosphamide) + TH (Taxol® + Herceptin®) is a Chemotherapy Regimen for Breast Cancer - early stage. How does Dose-Dense AC + TH work? Doxorubicin, cyclophosphamide, and paclitaxel are designed to kill or slow the growth of cancer cells.
For the pertuzumab group, the cost of pertuzumab was the main factor. The incremental cost difference between the 2 groups was $192 139. The main contributors of the incremental cost differences included the costs of pertuzumab (60%), outpatient cancer treatment delivery (24%), and trastuzumab (15%).
2 Σεπ 2021 · The mean QALY gain per patient compared with TCH was 0.25 with ACTH, while the incremental costs were $US 13,142. The incremental cost-effectiveness ratio (ICER) of AC-TH versus TCH was $US 52,565 per QALY gained.
16 Ιουλ 2018 · If your doctor has recommended the chemo regime AC + T for breast cancer, here's what you should know about how it works and the potential side effects.
9 Μαρ 2021 · There is currently a paucity of literature addressing the costs of chemotherapy administration, and existing studies utilize a patchwork of reporting methodologies which renders direct comparison challenging. Our results demonstrate that the cost of administering chemotherapy is approximately $125–150/hour, globally.
